Translational Development converts 4.66M Class B shares to Class A; no cash proceeds

Translational Development Acquisition Corp.

4,657,499 Class B ordinary shares converted to an equal number of Class A shares by Sponsor TDAC Partners LLC.
Conversion effected under Section 3(a)(9) exemption; shares unregistered, no underwriter or commissions involved.
Trust account unaffected; per-share redemption value remains ~$10.69 as of June 12, 2026.
Post-conversion: 21,907,499 Class A shares and 1 Class B share outstanding.

Key facts

Extracted from this filing and checked against the source text.

Equity Issuances SEC 8-K Item 3.02/3.03 confidence 0.95

Translational Development Acquisition Corp. issued 4,657,499 Class A ordinary shares of common stock to TDAC Partners LLC (the Sponsor) for no cash proceeds to the Company.

Security: common stock
Shares: 4,657,499 Class A ordinary shares
Purchaser: TDAC Partners LLC (the Sponsor)
Consideration: no cash proceeds to the Company

Exact text from the filing

On June 12, 2026, Translational Development Acquisition Corp., a Cayman Islands exempted company (the “Company”), issued an aggregate of 4,657,499 Class A ordinary shares, par value $0.0001 per share (the “Class A Ordinary Shares”), to TDAC Partners LLC (the “Sponsor”), upon the conversion (the “Conversion”) of an equal number of Class B ordinary shares, par value $0.0001 per share (the “Class B Ordinary Shares”), held by the Sponsor.

View on SEC.gov

226 equity issuances filed in the last 30 days. Browse all equity issuances →

Translational Development Acquisition Corp. filing history →

Source: SEC EDGAR

accession 0001104659-26-073428

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.